BioTech Examples Health Policy Medicare 
Health Populi
JUNE 24, 2021
In the larger public and population health context, on the patient side, we can expect the burden of disease beyond COVID to increase due to postponed care and treatment backlogs. for example, for heart disease and cardiovascular complications as well as for cancers. This has been found to be the case in the U.S., spends on NASA.
Health Populi
MAY 8, 2019
In 2018, we saw more incentives to inspire adherence to prescription drug regimens, particularly in Medicare Part D along with increasing focus by pharmacists and providers. Just under 9% of patients across all three health plan types had over $500 in OOP costs in 2018. A cost of $125 or more yields abandonment of at least 50%.
Health Populi
AUGUST 16, 2021
There is one health care public policy issue that unites U.S. voters across political party: that is the consumer-facing costs of prescription drugs.
Expert insights. Personalized for you.
270 
Let's personalize your content